Increase aspirin use for secondary prevention of atherosclerotic cardiovascular disease — HDS‑08 Data

Status: Little or no detectable change

Most Recent Data:
69.0 percent (2017-20) *

Target:
69.4 percent *

Desired Direction:
Increase desired

Baseline:
63.5 percent of adults aged 40 years and over with a history of cardiovascular disease were using aspirin in 2013-16 *

* Age adjusted to the year 2000 standard population.

Show disparities data

Show confidence interval (CI) View CI in the chart by hovering over a data point.

Show standard error (SE) View SE in the chart by hovering over a data point.

Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available

Population	2013-16	2017-20
Total	63.5 CI 60.4 / 66.5 SE 2.116	69.0 CI 63.6 / 74.1 SE 4.081

Data Source: National Health and Nutrition Examination Survey (NHANES), CDC/NCHS

Adults with cardiovascular disease using aspirin to prevent recurrent cardiovascular events by

#: Standard errors and confidence intervals are not available for this population group.

*: Age adjusted to the year 2000 standard population.

◊: Unless otherwise noted, data represent "percent, 40+ years"

†: Target is not applicable for this demographic group.

DSU: Data do not meet the criteria for statistical reliability, data quality, or confidentiality.

DNA: Data have not been analyzed.

DNC: Data for specific population not collected.

--- : Data are not available.